Alnylam Pharmaceuticals, Inc.
METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS
Last updated:
Abstract:
The present invention provides methods for treating or preventing TTR-associated diseases using RNAi agents, e.g., double stranded RNAi agents, that target the transthyretin (TTR) gene.
Status:
Application
Type:
Utility
Filling date:
15 Dec 2017
Issue date:
21 Nov 2019